Commentary on "Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial"

被引：0
|
作者：
Poh, Sharon S. [1 ,2 ]
Wee, Joseph T. S. [1 ,2 ]
机构：
[1] Natl Canc Ctr Singapore, Div Radiat Oncol, Singapore 169610, Singapore
[2] Duke NUS Med Sch, Oncol Acad Clin Program, Singapore, Singapore
来源：
CHINESE CLINICAL ONCOLOGY | 2022年
关键词：
NASOPHARYNGEAL CARCINOMA; MRI;
D O I：
10.21037/cco-22-73
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] SUGAR-DIP trial: oral medication strategy versus insulin for diabetes in pregnancy, study protocol for a multicentre, open-label, non-inferiority, randomised controlled trial
    de Wit, Leon
    Rademaker, Doortje
    Voormolen, Daphne N.
    Akerboom, Bettina M. C.
    Kiewiet-Kemper, Rosalie M.
    Soeters, Maarten R.
    Verwij-Didden, Marion A. L.
    Assouiki, Fahima
    Schippers, Daniela H.
    Vermeulen, Mechteld A. R.
    Kuppens, Simone M. I.
    Oosterwerff, Mirjam M.
    Zwart, Joost J.
    Diekman, Mattheus J. M.
    Vogelvang, Tatjana E.
    Gallas, P. Rob J.
    Galjaard, Sander
    Visser, Willy
    Horree, Nicole
    Klooker, Tamira K.
    Laan, Rosemarie
    Heijligenberg, Rik
    Huisjes, Anjoke J. M.
    van Bemmel, Thomas
    van Meir, Claudia A.
    van den Beld, Annewieke W.
    Hermes, Wietske
    Vidarsdottir, Solrun
    Veldhuis-Vlug, Anneke G.
    Dullemond, Remke C.
    Jansen, Henrique J.
    Sueters, Marieke
    de Koning, Eelco J. P.
    van Laar, Judith O. E. H.
    Wouters-van Poppel, Pleun
    Sanson-van Praag, Marina E.
    van den Akker, Eline S.
    Brouwer, Catherine B.
    Hermsen, Brenda B.
    Potter van Loon, Bert Jan
    van der Heijden, Olivier W. H.
    de Galan, Bastiaan E.
    van Leeuwen, Marsha
    Wijbenga, Johanna A. M.
    de Boer, Karin
    van Bon, Arianne C.
    van der Made, Flip W.
    Eskes, Silvia A.
    Zandstra, Mirjam
    van Houtum, William H.
    BMJ OPEN, 2019, 9 (08):
  • [42] Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015) an open-label, multicentre, randomised, phase 3 non-inferiority trial
    Yang, Wenyu
    Cai, Jiaoyang
    Shen, Shuhong
    Gao, Ju
    Yu, Jie
    Hu, Shaoyan
    Jiang, Hua
    Fang, Yongjun
    Liang, Changda
    Ju, Xiuli
    Wu, Xuedong
    Zhai, Xiaowen
    Tian, Xin
    Wang, Ningling
    Liu, Aiguo
    Jiang, Hui
    Jin, Runming
    Sun, Lirong
    Yang, Minghua
    Leung, Alex W. K.
    Pan, Kaili
    Zhang, Yingchi
    Chen, Jing
    Zhu, Yiping
    Zhang, Hui
    Li, Chunfu
    Yang, Jun J.
    Cheng, Cheng
    Li, Chi-Kong
    Tang, Jingyan
    Zhu, Xiaofan
    Pui, Ching-Hon
    LANCET ONCOLOGY, 2021, 22 (09): : 1322 - 1332
  • [43] Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial
    Hill, Louise F.
    Clements, Michelle N.
    Turner, Mark A.
    Dona, Daniele
    Lutsar, Irja
    Jacqz-Aigrain, Evelyne
    Heath, Paul T.
    Roilides, Emmanuel
    Rawcliffe, Louise
    Alonso-Diaz, Clara
    Baraldi, Eugenio
    Dotta, Andrea
    Ilmoja, Mari-Liis
    Mahaveer, Ajit
    Metsvaht, Tuuli
    Mitsiakos, George
    Papaevangelou, Vassiliki
    Sarafidis, Kosmas
    Walker, A. Sarah
    Sharland, Michael
    LANCET CHILD & ADOLESCENT HEALTH, 2022, 6 (01): : 49 - 59
  • [44] Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
    Rummel, Mathias J.
    Niederle, Norbert
    Maschmeyer, Georg
    Banat, G. Andre
    von Gruenhagen, Ulrich
    Losem, Christoph
    Kofahl-Krause, Dorothea
    Heil, Gerhard
    Welslau, Manfred
    Balser, Christina
    Kaiser, Ulrich
    Weidmann, Eckhart
    Duerk, Heinz
    Ballo, Harald
    Stauch, Martina
    Roller, Fritz
    Barth, Juergen
    Hoelzer, Dieter
    Hinke, Axel
    Brugger, Wolfram
    LANCET, 2013, 381 (9873): : 1203 - 1210
  • [45] Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
    Uesaka, Katsuhiko
    Boku, Narikazu
    Fukutomi, Akira
    Okamura, Yukiyasu
    Konishi, Masaru
    Matsumoto, Ippei
    Kaneoka, Yuji
    Shimizu, Yasuhiro
    Nakamori, Shoji
    Sakamoto, Hirohiko
    Morinaga, Soichiro
    Kainuma, Osamu
    Imai, Koji
    Sata, Naohiro
    Hishinuma, Shoichi
    Ojima, Hitoshi
    Yamaguchi, Ryuzo
    Hirano, Satoshi
    Sudo, Takeshi
    Ohashi, Yasuo
    LANCET, 2016, 388 (10041): : 248 - 257
  • [46] Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial
    Mackenzie, Isla S.
    Ford, Ian
    Nuki, George
    Hallas, Jesper
    Hawkey, Christopher J.
    Webster, John
    Ralston, Stuart H.
    Walters, Matthew
    Robertson, Michele
    De Caterina, Raffaele
    Findlay, Evelyn
    Perez-Ruiz, Fernando
    McMurray, John J. V.
    MacDonald, Thomas M.
    LANCET, 2020, 396 (10264): : 1745 - 1757
  • [47] Multicentre, randomised, open-label, non-inferiority trial comparing the effectiveness and safety of ductal lavage versus oral corticosteroids for idiopathic granulomatous mastitis: a study protocol
    Hu, Tingting
    Li, Shunrong
    Huang, Heng
    Huang, Hui
    Tan, Luyuan
    Chen, Yanbo
    Deng, Heran
    Wu, Jiannan
    Zhu, Liling
    Zhang, Jian
    Su, Fengxi
    Chen, Kai
    BMJ OPEN, 2020, 10 (10):
  • [48] Early versus differed arterial catheterisation in critically ill patients with acute circulatory failure: a multicentre, open-label, pragmatic, randomised, non-inferiority controlled trial: the EVERDAC protocol
    Muller, Gregoire
    Kamel, Toufik
    Contou, Damien
    Ehrmann, Stephan
    Martin, Maelle
    Quenot, Jean-Pierre
    Lacherade, Jean-Claude
    Boissier, Florence
    Monnier, Alexandra
    Vimeux, Sylvie
    Houdard, Solene Brunet
    Tavernier, Elsa
    Boulain, Thierry
    BMJ OPEN, 2021, 11 (09):
  • [49] Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial
    Vogel, Arndt
    Qin, Shukui
    Kudo, Masatoshi
    Su, Yun
    Hudgens, Stacie
    Yamashita, Tatsuya
    Yoon, Jung-Hwan
    Fartoux, Laetitia
    Simon, Krzysztof
    Lopez, Carlos
    Sung, Max
    Mody, Kalgi
    Ohtsuka, Tatsuroh
    Tamai, Toshiyuki
    Bennett, Lee
    Meier, Genevieve
    Breder, Valery
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (08): : 649 - 658
  • [50] Radiotherapy alone versus concurrent chemoradiotherapy in intermediate risk nasopharyngeal carcinoma: A multicentre, open-label, noninferiority, randomised phase III trial.
    Ma, Jun
    Tang, Ling-Long
    Guo, Rui
    Zhang, Ning
    Deng, Bin
    Zhang, Yuan
    Huang, Jing
    Zhou, Guan-Qun
    Hu, Weihan
    Mao, Yan-Ping
    Li, Wen-Fei
    Liu, Qing
    Xie, Fangyun
    Sun, Ying
    Chen, Lei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345